Article Text

Download PDFPDF
CASE REPORT
Gambling disorder: a side effect of an off-label prescription of baclofen—literature review
  1. Morgane Guillou-Landreat1,2,
  2. Caroline Victorri Vigneau3,4,
  3. Marie Gerardin3
  1. 1ERCR SPURBO, Department of Addictive Disorders, Université de Bretagne Occidentale, Brest, France
  2. 2Addictology Department, Brest University Hospital, Brest, France
  3. 3Clinical Pharmacology, CHU Nantes, Nantes, Pays de la Loire, France
  4. 4EA 4275 “Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Sciences,” Nantes University, Nantes, France
  1. Correspondence to Dr Morgane Guillou Landreat, morgane.guillou{at}chu-brest.fr

Summary

The use of high-dose baclofen emerged in 2008 in the treatment of alcohol-use disorders. Its prescription is still off-label in France, but recent trials have suggested the interest of using high doses for alcohol dependence, so we have to deal with an increase in its use. However, we still have few data about the adverse effects of a high-dose baclofen prescription, especially in complex addictive disorders. We present a case of a 32-year-old man who sought treatment for gambling disorders (GDs). He had complex addictive disorders, including alcohol-use disorders and GDs. He developed a severe GD, after treatment with a high dose of baclofen. The maximum dose was 160 mg/day, prescribed for his alcohol-use disorders. According to the Naranjo algorithm, the score was +7, it enabled to conclude that problem of gambling was probably imputable to baclofen. We discuss this case with reference to literature.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.